3 Previously, mainstay treatment options for glycemic control included metformin, sulfonylureas (glimepiride, glipizide, and glyburide), thiazolidinediones (pioglitazone), and dipeptidyl peptidase-4 inhibitors (alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia)
A New Era in Weight Loss Obesity is not simply a matter of willpower
This is an FDA-approved statin medication prescribed for cholesterol management and cardiovascular risk reduction for its indicated uses
This gradual approach reduces gastrointestinal side effects and allows monitoring of clinical response
Microorganisms 8:15871609
Your body adapts to consistent medication levels through a process called receptor desensitization, and lifestyle drift often accompanies initial weight loss success